A new national study showed promising results for protecting newborns at risk of brain damage.
Researchers discovered that a 27-year-old drug helps reduce HIE or Hypoxic Ischemic Encephalopathy.
It's a dysfunction in a baby's nervous system that occurs during birth that restricts oxygen flow to the brain.
Typically, doctors treated HIE by cooling a child's body temperature to accelerate healing.
However, researchers found that the cooling procedure and the drug Erythropoietin was more effective at reducing the risk of brain damage.
The research was conducted at seven sites, including the Arkansas Children's Hospital in Little Rock.
Segment Sponsored By: Mercy Health System